A Two-Period Open-Label, Single-Dose Crossover Study in Healthy Volunteers to Evaluate the Drug–Drug Interaction Between Cimetidine and Inhaled Extrafine CHF 5993

BACKGROUND AND OBJECTIVES: CHF 5993 is an extrafine ‘triple therapy’ combination of the long-acting muscarinic antagonist glycopyrronium bromide (GB), the long-acting β(2)-agonist formoterol fumarate (FF), and the inhaled corticosteroid beclometasone dipropionate (BDP). It is in development for chro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariotti, Fabrizia, Ciurlia, Giorgia, Spaccapelo, Luca, Muraro, Annamaria, Acerbi, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340825/
https://www.ncbi.nlm.nih.gov/pubmed/27209586
http://dx.doi.org/10.1007/s13318-016-0345-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340825/
https://www.ncbi.nlm.nih.gov/pubmed/27209586
http://dx.doi.org/10.1007/s13318-016-0345-2

Ejemplares similares